Edge Advisors’s Chemours CC Stock Holding History

Edge Advisors’s Portfolio CC Stock Details CC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-686	Closed	-$26K	–	933
2017 Q1	$26K	Hold	686	–	–	﹤0.01%	639
2016 Q4	$15K	Buy	+686	New	+$14.1K	﹤0.01%	649

Other funds holding CC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Edge Advisors's CC Position: Q2 2017 in Review

Edge Advisors sold out of Chemours (CC) in Q2 2017, closing a stake of 686 shares — an estimated $26K sold.

Edge Advisors first reported a position in CC in Q4 2016 and held it in 2 quarters. The position peaked at $26K in Q1 2017. 462 funds tracked by Wall St. Rank hold CC as of Q2 2017.

Edge Advisors reported no remaining Chemours position as of Q2 2017 after selling out during the quarter.
Edge Advisors sold 686 Chemours shares in Q2 2017, an estimated $26K.
Edge Advisors first reported a position in Chemours in Q4 2016 and held it in 2 quarters.
Edge Advisors's Chemours position peaked at $26K in Q1 2017.
462 funds tracked by Wall St. Rank held Chemours as of Q2 2017.

Based on Edge Advisors's 13F filing for Q2 2017, filed 27 Oct 2017.